Stratifying the effects of SGLT2i View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04-03

AUTHORS

Irene Fernández-Ruiz

ABSTRACT

Two prespecified analyses of the DECLARE–TIMI 58 trial show that in patients with type 2 diabetes mellitus, dapagliflozin has greater cardiovascular benefit in those with heart failure with reduced ejection fraction at baseline and in those with prior myocardial infarction

PAGES

1

References to SciGraph publications

  • 2018-01-25. Effect of glucose-lowering therapies on heart failure in NATURE REVIEWS CARDIOLOGY
  • Journal

    TITLE

    Nature Reviews Cardiology

    ISSUE

    N/A

    VOLUME

    N/A

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41569-019-0198-x

    DOI

    http://dx.doi.org/10.1038/s41569-019-0198-x

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1113182216

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30944408


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "author": [
          {
            "affiliation": {
              "name": [
                "Nature Reviews Cardiology, . nrcardio@nature.com."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fern\u00e1ndez-Ruiz", 
            "givenName": "Irene", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrcardio.2017.211", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100622889", 
              "https://doi.org/10.1038/nrcardio.2017.211"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/circulationaha.119.040130", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1112857294"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/circulationaha.119.039996", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1112858999"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-04-03", 
        "datePublishedReg": "2019-04-03", 
        "description": "Two prespecified analyses of the DECLARE\u2013TIMI 58 trial show that in patients with type 2 diabetes mellitus, dapagliflozin has greater cardiovascular benefit in those with heart failure with reduced ejection fraction at baseline and in those with prior myocardial infarction", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/s41569-019-0198-x", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1345537", 
            "issn": [
              "1423-5528", 
              "1662-629X"
            ], 
            "name": "Nature Reviews Cardiology", 
            "type": "Periodical"
          }
        ], 
        "name": "Stratifying the effects of SGLT2i", 
        "pagination": "1", 
        "productId": [
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41569-019-0198-x"
            ]
          }, 
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "5216c084e27941d81ea52ba4788977656532d93aa732cc875ed6165d601bafa2"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1113182216"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "101500075"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30944408"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41569-019-0198-x", 
          "https://app.dimensions.ai/details/publication/pub.1113182216"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-15T09:23", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000376_0000000376/records_56185_00000006.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://www.nature.com/articles/s41569-019-0198-x"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41569-019-0198-x'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41569-019-0198-x'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41569-019-0198-x'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41569-019-0198-x'


     

    This table displays all metadata directly associated to this object as RDF triples.

    63 TRIPLES      20 PREDICATES      27 URIs      18 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41569-019-0198-x schema:author N86355483654443cca74bda8e8353c5d7
    2 schema:citation sg:pub.10.1038/nrcardio.2017.211
    3 https://doi.org/10.1161/circulationaha.119.039996
    4 https://doi.org/10.1161/circulationaha.119.040130
    5 schema:datePublished 2019-04-03
    6 schema:datePublishedReg 2019-04-03
    7 schema:description Two prespecified analyses of the DECLARE–TIMI 58 trial show that in patients with type 2 diabetes mellitus, dapagliflozin has greater cardiovascular benefit in those with heart failure with reduced ejection fraction at baseline and in those with prior myocardial infarction
    8 schema:genre research_article
    9 schema:inLanguage en
    10 schema:isAccessibleForFree false
    11 schema:isPartOf sg:journal.1345537
    12 schema:name Stratifying the effects of SGLT2i
    13 schema:pagination 1
    14 schema:productId N67953b3d694f4c0f97e17c2c7d005a52
    15 N690562d0c96d42ecb0bf43111321c59a
    16 N8686f00f67e84486b4ee465da63bd5f8
    17 N8e16667aeacb4cf48e5bbbe81b10a8b0
    18 Nba980bd7a466494885f8fb09fd43a465
    19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113182216
    20 https://doi.org/10.1038/s41569-019-0198-x
    21 schema:sdDatePublished 2019-04-15T09:23
    22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    23 schema:sdPublisher N043ce32000074ad7b31ca6dc77ab6312
    24 schema:url https://www.nature.com/articles/s41569-019-0198-x
    25 sgo:license sg:explorer/license/
    26 sgo:sdDataset articles
    27 rdf:type schema:ScholarlyArticle
    28 N043ce32000074ad7b31ca6dc77ab6312 schema:name Springer Nature - SN SciGraph project
    29 rdf:type schema:Organization
    30 N14f2abbdb9124fc2aac2c1feaaf8a260 schema:name Nature Reviews Cardiology, . nrcardio@nature.com.
    31 rdf:type schema:Organization
    32 N349f334d39fe4c6799e5a8aae38bd5bc schema:affiliation N14f2abbdb9124fc2aac2c1feaaf8a260
    33 schema:familyName Fernández-Ruiz
    34 schema:givenName Irene
    35 rdf:type schema:Person
    36 N67953b3d694f4c0f97e17c2c7d005a52 schema:name pubmed_id
    37 schema:value 30944408
    38 rdf:type schema:PropertyValue
    39 N690562d0c96d42ecb0bf43111321c59a schema:name dimensions_id
    40 schema:value pub.1113182216
    41 rdf:type schema:PropertyValue
    42 N86355483654443cca74bda8e8353c5d7 rdf:first N349f334d39fe4c6799e5a8aae38bd5bc
    43 rdf:rest rdf:nil
    44 N8686f00f67e84486b4ee465da63bd5f8 schema:name nlm_unique_id
    45 schema:value 101500075
    46 rdf:type schema:PropertyValue
    47 N8e16667aeacb4cf48e5bbbe81b10a8b0 schema:name doi
    48 schema:value 10.1038/s41569-019-0198-x
    49 rdf:type schema:PropertyValue
    50 Nba980bd7a466494885f8fb09fd43a465 schema:name readcube_id
    51 schema:value 5216c084e27941d81ea52ba4788977656532d93aa732cc875ed6165d601bafa2
    52 rdf:type schema:PropertyValue
    53 sg:journal.1345537 schema:issn 1423-5528
    54 1662-629X
    55 schema:name Nature Reviews Cardiology
    56 rdf:type schema:Periodical
    57 sg:pub.10.1038/nrcardio.2017.211 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100622889
    58 https://doi.org/10.1038/nrcardio.2017.211
    59 rdf:type schema:CreativeWork
    60 https://doi.org/10.1161/circulationaha.119.039996 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112858999
    61 rdf:type schema:CreativeWork
    62 https://doi.org/10.1161/circulationaha.119.040130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112857294
    63 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...